TACROLIMUS FOR IMMUNOSUPPRESSION IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIDES. Jabs DA, Thorne JE, Wilkins CS, Habbu KA, et al. Retina 2023;43:1480-1486.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jabs DA, Thorne JE, Wilkins CS, Habbu KA, et al. TACROLIMUS FOR IMMUNOSUPPRESSION IN PATIENTS WITH NONINFECTIOUS INTERMEDIATE, POSTERIOR, OR PANUVEITIDES. Retina 2023;43:1480-1486.
PMID: 37184495